FDA approves Biogen-Sage Therapeutics pill for postpartum depression

eAwazMedicine

Washington – The US Food and Drug Administration (FDA) approved Biogen BIIB.O and Sage Therapeutics’ SAGE.O oral pill to treat postpartum depression (PPD) in adults. The companies had sought the FDA’s approval for the drug, Zurzuvae, to treat major depressive disorderdrug, Zurzuvae, to treat major depressive disorder (MDD), or clinical depression, as well as postpartum depression, which affect millions of …

Ketamine effectively treats severe depression clinical trial

eAwazMedicine

Australia – A new study published in the British Journal of Psychiatry says more than one in five patients with treatment-resistant depression saw severe depression symptoms disappear after receiving ketamine injections in a clinical trial, while one third reported their symptoms improved by at least 50 per cent. Lead author Colleen Loo said in a news release: “We found that …